Other languages Cosmo Pharmaceuticals N.V.

Equities

COPN

NL0011832936

Market Closed - Swiss Exchange Other stock markets 11:31:28 2024-05-28 am EDT			5-day change	1st Jan Change
71.2 ^CHF	+1.40%		-1.39%	+39.88%

Apr. 26	Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024	CI
Apr. 25	Cosmo Pharmaceuticals Names New CEO, Chairman	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cosmo darf definitive Jahresrechnung 2023 bis Ende Mai veröffentlichen	Apr. 29
Cosmo pourra publier ses résultats 2023 définitifs d'ici au 31 mai	Apr. 29
Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024	Apr. 26
Cosmo Pharmaceuticals Names New CEO, Chairman	Apr. 25
Changements à la tête de Cosmo	Apr. 25
Cosmo ernennt Giovanni Di Napoli zum neuen CEO - Della Chà wird VR-Präsident	Apr. 25
Cosmo treibt mit dem Partner Medtronic endoskopische Versorgung voran	Apr. 12
Cosmo Pharmaceuticals N.V. Proposes Dividend Payment for 2024	Mar. 20
Cosmo Pharmaceuticals N.V. Provides Earnings Guidance for the Year 2024 and Revenue Guidance for 2025	Mar. 20
Cosmo voit ses revenus reculer en 2023	Mar. 20
Cosmo stellt trotz Gewinnrückgang verdoppelte Dividende in Aussicht	Mar. 20
Cosmo Pharmaceuticals' FY23 Profit, Revenue Drops	Mar. 20
Cosmo Pharmaceuticals N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 19
Bourse Zurich: le SMI finit sous la barre des 11'600 points	Mar. 19
Cosmo: feu vert pour la commercialisation du Winlevi aux antipodes	Mar. 19
Cosmo erhält Zulassung für Winlevi in Australien	Mar. 19
Cosmo Pharmaceuticals Partner Gets Regulatory Approval for Acne Treatment in Australia	Mar. 19
Bourse Zurich: en vert à l'entame d'une "semaine banques centrales"	Dec. 11
Les actions en mouvement : Solvay s'effondre dans le cadre de sa scission	Dec. 11
Bourse Zurich: prudence en entame de semaine dominée par les banques centrales	Dec. 11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Cosmo Pharmaceuticals N.V.

Equities

COPN

NL0011832936

Other languages

Filters